ALPMY

ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY)

About ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY)

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.

Details

Daily high

$14.71

Daily low

$14.62

Price at open

$14.63

52 Week High

$17.35

52 Week Low

$8.97

Market cap

25.9B

Dividend yield

1.74%

Volume

169,802

Avg. volume

152,490

P/E ratio

13.34

ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. News